» Articles » PMID: 11686545

Severe Respiratory Failure Secondary to Cushing's Myopathy

Overview
Publisher Springer
Specialty Endocrinology
Date 2001 Nov 1
PMID 11686545
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We report a 55-year-old woman with typical clinical, biochemical and radiological features of Cushing's disease, who developed a severe respiratory insufficiency as the main symptom. She also complained of proximal muscle weakness over the last year and progressive dyspnea over the last four months. Bronchospasm, respiratory infection or cardiologic dysfunction were excluded. Arterial blood gas analysis showed severe respiratory insufficiency with hypoxemia and hypercapnia, respiratory acidosis and a normal alveolar-arterial oxygen gradient. Spirometry and plethysmography showed a restrictive ventilatory failure and maximum inspiratory and expiratory pressures were reduced. These findings were strongly suggestive of neuromuscular disease. Serum creatine kinase, aldolase, sodium, potassium and thyroid function tests were normal. An electromyogram and a muscle biopsy confirmed myopathic disease. Ketoconazole therapy improved her symptoms and respiratory function tests. In conclusion although proximal myopathy is a frequent presenting symptom of Cushing's syndrome, involvement of respiratory muscles with severe restrictive ventilatory dysfunction has not been previously reported as the main initial feature of Cushing's disease. Medical treatment of hypercortisolism improves muscle strength and resolves the respiratory insufficiency.

Citing Articles

Cushing's syndrome and COVID-19.

Attia A, Bertherat J Pituitary. 2024; 27(6):945-954.

PMID: 39541074 DOI: 10.1007/s11102-024-01466-0.


Glucocorticoid excess and COVID-19 disease.

Guarnotta V, Ferrigno R, Martino M, Barbot M, Isidori A, Scaroni C Rev Endocr Metab Disord. 2020; 22(4):703-714.

PMID: 33025384 PMC: 7538187. DOI: 10.1007/s11154-020-09598-x.


An unusual case of shortness of breath.

Wan Muhammad Hatta S, Kandaswamy L, Gherman-Ciolac C, Mann J, Buch H Endocrinol Diabetes Metab Case Rep. 2018; 2018.

PMID: 30087779 PMC: 6063989. DOI: 10.1530/EDM-18-0074.


Steroid myopathy: some unresolved issues.

Minetto M, Lanfranco F, Motta G, Allasia S, Arvat E, DAntona G J Endocrinol Invest. 2011; 34(5):370-5.

PMID: 21677507 DOI: 10.1007/BF03347462.

References
1.
Ross E, Linch D . Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982; 2(8299):646-9. DOI: 10.1016/s0140-6736(82)92749-0. View

2.
Yanovski J, Cutler Jr G . Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am. 1994; 23(3):487-509. View

3.
Olafsson E, Jones Jr H, Guay A, Thomas C . Myopathy of endogenous Cushing's syndrome: a review of the clinical and electromyographic features in 8 patients. Muscle Nerve. 1994; 17(6):692-3. DOI: 10.1002/mus.880170625. View

4.
Ross E, Linch D . The clinical response to treatment in adult Cushing's syndrome following remission of hypercortisolaemia. Postgrad Med J. 1985; 61(713):205-11. PMC: 2418188. DOI: 10.1136/pgmj.61.713.205. View

5.
Khaleeli A, Betteridge D, EDWARDS R, Round J, Ross E . Effect of treatment of Cushing's syndrome on skeletal muscle structure and function. Clin Endocrinol (Oxf). 1983; 19(4):547-56. DOI: 10.1111/j.1365-2265.1983.tb00030.x. View